The Michael J. Fox Foundation has recently donated 5.5 million kroner (€750,000) to the pharmaceutical firm Lundbeck based in Denmark. The CEO of the Michael J. Fox Foundation (MJFF), Todd Sherer, said that the organization’s main goal is to advance research so that millions of people with Parkinson’s disease will have better therapy options.
The donation was given in the form of a grant to finance two research projects for the development potential of new medicines against Parkinson’s disease. One project will focus on preventative treatment and the other will look at symptomatic treatment.
Kim Anderson, head of research for Lundbeck, said that the company is proud to have MJFF as a research partner. The MJFF has, over the years, donated over 1.9bn kroner to research to find a cure for the disease. Michael J. Fox was diagnosed with it in 1991.
